• 생물정신의학
• /
• 제25권2호
• /
• pp.21-30
• /
• 2018

Attention deficit hyperactivity disorder (ADHD) is a common childhood psychiatric disorder. Recently, it has been suggested that brain-derived neurotropic factor (BDNF) may play a role in the pathogenesis of ADHD. Our aim of this review is to understand the physiological functions of BDNF and its potential relationship with ADHD and therapeutic approaches of ADHD. Searches were conducted in Pubmed and Research Information Service System (RISS). In this review, we summarized important literatures for the physiological functions of BDNF in neurodevelopment, change of serum BDNF level in ADHD, association of BDNF polymorphism and ADHD and potential association of treatment of ADHD with serum BDNF level. Further studies are required to more clearly understand the source and the role of BDNF in ADHD and to develop BDNF based-ADHD treatement.

• 대한감각통합치료학회지
• /
• 제18권3호
• /
• pp.1-13
• /
• 2020

목적 : 본 연구는 주의력결핍 과잉행동장애(Attention Deficit Hyperactivity Disorder; ADHD) 아동과 일반 아동을 대상으로 감각처리능력과 시지각 기술을 비교하고자 하였다. 연구방법 : 연구대상은 지역적 환경이 동일한 아동으로 선정하였다. 소아정신과에서 ADHD로 진단받은 아동 25명과 초등학교 1, 2학년의 일반 아동 51명을 대상으로 감각처리능력과 시지각 기술을 평가하였다. 아동의 감각처리능력을 측정하기 위해 감각프로파일(Sensory Profile; SP)을 사용하였고 시지각 기술을 측정하기 위해 한국판 시지각 발달검사(Korean Developmental Test of Visual Perception-2; K-DTVP-2)를 사용하였다. 두 군 간의 감각처리능력과 시지각 기술의 차이는 독립표본 t 검정을 사용하여 분석하였다. 결과 : ADHD 아동과 일반 아동의 감각프로파일(SP)의 모든 하위 영역에서 통계적으로 유의한 차이를 보였다. 감각요인을 비교한 결과 감각예민을 제외한 8가지 요인에서 통계적으로 유의한 차이를 보였다. K-DTVP-2의 모든 시지각 지수에서 유의한 차이를 보였다. K-DTVP-2의 하위 항목 표준점수를 비교한 결과 공간위치(p=.031), 도형-배경(p=.001), 시각 통합(p=.005), 눈-손 협응(p=.000), 따라 그리기(p=.044), 공간관계(p=.006)에서 통계적으로 유의한 차이를 보였다. 결론 : 본 연구는 임상에서 ADHD 아동의 행동의 특성을 이해하는데 감각처리능력과 시지각 기술이 중요하다는 근거가 되며 ADHD 아동의 평가, 교육 및 연구에 도움을 제공할 수 있다는 점에서 의미가 있다.

• Journal of the Korean Academy of Child and Adolescent Psychiatry
• /
• 제24권4호
• /
• pp.220-227
• /
• 2013

Objectives : This study aims to investigate the clinical characteristics and neuropsychological profiles of children with attention-deficit hyperactivity disorder (ADHD) and their siblings. Methods : Eighteen children (age $8.2{\pm}1.7$ years, 12 boys) with ADHD and their 18 siblings (age $7.8{\pm}1.6$ years, 8 boys) completed Continuous Performance (CPT), Stroop, Children's Trail Making, Rey-Kim Memory, and Kim's Frontal Executive Function tasks. The parents of these subjects underwent the Attention-Deficit/Hyperactivity Disorder Rating Scale (ARS), 10-item Parent General Behavior Inventory (P-GBI), and the Social Responsiveness Scale (SRS). Paired t-tests were used. Results : The inattention (p=.020), and hyperactivity-impulsivity (p=.001), scores of the ARS and the P-GBI score (p=.004) were significantly higher in children with ADHD than in their siblings. Deficits in social communication and motivation on SRS were higher in children with ADHD than in their siblings (p=.017 and p=.011, respectively). Z-scores of omission and commission errors as well as response time variability on visual CPT and omission errors on auditory CPT were in clinically significant range, and z-score of omission errors on auditory CPT was in borderline range in siblings. Omission (p=.018) and commission errors on Visual CPT (p=.007) were significantly higher in children with ADHD compared to their siblings. Recognition efficiency on Kim's Frontal Executive Function Task was lower in children with ADHD compared to their siblings, but in normal range in both groups. Stroop interference and figure fluency on Kims Frontal Executive Function Task were in borderline range in ADHD group, and figure fluency was in borderline range in siblings. Conclusion : Our results support a preliminary evidence for mild degree of attention deficit in ADHD siblings. Further studies are needed to examine the cognitive functions of siblings with ADHD in larger samples.

• Journal of the Korean Academy of Child and Adolescent Psychiatry
• /
• 제22권4호
• /
• pp.253-261
• /
• 2011

Objectives : This study aimed to investigate the efficacy and safety of Metadate CD (MCD) when given to Korean children and adolescents with attention-deficit hyperactivity disorder (ADHD). We also explored the effects of the drug on diverse neuro-cognitive functions. Methods : Ninety-one subjects with ADHD (mean age 8.6${\pm}$2.2 years) were recruited at 6 outpatient clinics in Seoul, Korea. We used the ADHD Rating Scale (ARS), Clinical Global Impression (CGI), and comprehensive attention test (CAT) to measure the drug's effects. Results : After 0.92${\pm}$0.32mg/kg/day of MCD were administered for 57.4${\pm}$7.6 days, there was a 48.5% reduction in the mean total ARS scores (p<.001). Fifty-seven subjects (64.8%) showed either much improved or very much improved outcomes on the CGI-Improvement scale. The CGI-Severity scale also decreased from an average of 4.7 to an average of 2.9 (p<.001). Errors and response time standard deviations of the CAT, sustained attention test-to-response tasks, the flanker test, and divided attention test scores decreased after treatment (p<.05). The forward memory span of the spatial working memory test scores increased (p<.05). Thirty-five patients (39.8%) experienced side effects, of which the most common were headache (14.8%), nausea (12.5%), and anorexia (9.1%). Conclusion : This open-label study suggests that MCD is effective and safe in improving the symptoms and neurocognitive functions of Korean children and adolescents with ADHD.

• Journal of the Korean Academy of Child and Adolescent Psychiatry
• /
• 제11권2호
• /
• pp.282-289
• /
• 2000

본 연구에서는 현재 주의력-결핍 및 과잉운동장애(Attention Deficit/Hyperactivity Disorder, 이하 ADHD)의 주요한 평가척도 중의 하나로서 이용되고 있는 한국아동인성검사(Korean Personality Inventory for Children, K-PIC)와 아동 ${\cdot}$ 청소년 행동평가척도(Korean Child Behavior Checklist KCBCL)의 임상적 타당도에 대해 살펴보고자 하였다. 피검자들은 ADHD의 하위 유형 중 주의력-결핍 우세형(ADHD-I)으로 진단된 환아 11명과 과잉 행동-충동 우세형 및 복합형(ADHD-H)로 진단된 환아 23명, 우울, 불안 등 정서적 문제로 진단(신경증 집단；N) 받은 정신과 외래 환아 16명, 정상아동 15명 등 총 65명이었다. 먼저 각 집단별로 분산분석을 실시하였고, 각각 행동 평정 척도의 변별력을 측정하기 위하여 판별분석을 실시하였다. 이 집단들의 K-PIC와 K-CBCL 결과들에 대한 전체(omnibus) F-검증 결과, K-PIC의 과잉행동(HPR) 척도와 K-CBCL의 주의집중문제(Attention Problems, 이하 AP) 척도들은 분산분석결과 유의한 차이를 보였다. 하지만 사후검증 결과, ADHD-I 집단과 ADHD-H 집단 그리고 신경증 집단 사이에 유의한 차이를 보이지 않는 반면, 그 세 집단은 모두 정상집단과 .05 유의도 수준 하에서 유의한 차이를 나타내었다. 이러한 결과는 K-PIC의 과잉행동(HPR) 척도와 K-CBCL의 주의집중문제(Attention Problems) 척도의 경우, 기본적으로 임상군과 정상군을 구별하는데는 유용하지만 임상군내에서의 세부 진단을 위해 사용하는 데는 한계가 있음을 시사해준다. 또한 본 연구 결과 상대적으로 HPR 척도는 ADHD-H type을 감별하는 데 더 유용한 반면, K-CBCL의 AP 척도는 ADHD-I type을 감별하는 데 더 큰 강점을 갖는 것으로 보이나, HPR척도와 AP 척도 중 어느 하나만을 사용하는 것보다는 병행하여 사용하는 것이 더 바람직한 것으로 보인다. 특히 cut-off score 면에서 두 척도 중 어느 하나에서 T 점수 65점 이상 상승할 때 ADHD로 진단내리는 경우, 가장 효과적으로 정분류율(true positive rate；sensitivity)과 정배제율(true negative rate；specificity)을 조화시킬 수 있는 결정규칙이 되는 것으로 나타났다.

• Journal of the Korean Academy of Child and Adolescent Psychiatry
• /
• 제1권1호
• /
• pp.89-93
• /
• 1990

주의력결핍 과잉운동장애로 진단, 치료를 받은 소아 및 청소년 환자 60명에 대해 methylphenidate, pemoline등 중추신경흥분제 치료의 효과 및 부작용에 관해 조사, 다음과 같은 결과를 얻었다. 조사대상 60명중 약물치료의 효과가 뚜렷하게 나타난 경우가 34명으로 절반을 넘었고, 효과가 드러나지 않은 경우는 8명에 지나지 않았다. 약물치료로 뚜렷한 호전을 보인 증상은 과잉운동, 주의산만 및 충동성 등이었고 이러한 행동상의 향상과 함께 학교성적의 향상도 보였다. 이러한 약물효과는 학령전기 어린이 및 청소년에 비해 학령기 어린이에게서 더 크게 나타났다. 60명중 25명은 부작용을 보이지 않았고 6명만이 심한 부작용을 보였는데 흔히 볼 수 있었던 부작용은 식욕감퇴, 불면 또는 안절부절못함 등이었다. 조사결과 이들 약물의 치료적 유용성이 단기치료를 통해서는 충분히 밝혀졌는데 이러한 결과는 장기적으로도 적용될 수 있으리라 생각된다.

• Journal of the Korean Academy of Child and Adolescent Psychiatry
• /
• 제25권2호
• /
• pp.89-94
• /
• 2014

Objectives : This study was conducted naturalistically in order to observe the long-term effects of attention-deficit hyperactivity disorder (ADHD) medications on growth rates among Korean school-aged boys with ADHD. Methods : Participants in the study were boys with ADHD aged 6 to 11 years who have taken ADHD medication, methylphenidate (extended release) or atomoxetine. They attended scheduled visits monthly or bimonthly for clinical assessment with measurement of height and weight. In this study, 35 boys with ADHD (mean age at baseline=$7.90{\pm}1.77$ years ; mean age at endpoint= $12.54{\pm}1.91$ years) were included, with a mean follow-up period of 4.64 years (${\pm}1.62$ years), ranging from 2 to 9.7 years. Height, weight, and body mass index (BMI) measurements were converted to "age-corrected Z-scores" using data from Growth Charts provided by the Korean Center for Disease Control and Prevention from 2007. Results : Age-corrected endpoint growth parameters (height, weight, BMI Z-scores) did not differ significantly from the baseline values (height t=0.027 ; weight t=-0.61 ; BMI t=-1.86, in paired t-test). Especially high correlation was observed between the baseline and endpoint height Z-scores (r=0.876, p<.001), for which the coefficient of determination $r^2$ was 0.767, meaning that the amount of variability in endpoint height Z-scores explained by the baseline height Z-scores was 76.7%. Conclusion : Our results suggested that the long-term effects of ADHD medications on growth parameters to be tolerable in Korean school-aged boys with ADHD.

• Journal of the Korean Academy of Child and Adolescent Psychiatry
• /
• 제25권2호
• /
• pp.65-72
• /
• 2014

Objectives : The objective of this study was to evaluate the treatment duration and adherence of osmotic-controlled release oral delivery system (OROS) methylphenidate for treatment of attention-deficit hyperactivity disorder (ADHD). Methods : A total of 843 children with ADHD were recruited : 213 children (25.3%) who had previously taken medications for ADHD and 630 drug-na$\ddot{i}$ve children (74.7%) were recruited. The dosage was adjusted according to the clinician's judgment. The primary efficacy endpoint of this study was treatment retention rate, which was estimated at Week 12 and Week 20 using the Kaplan-Meier curve. The Swanson, Nolan and Pelham-IV (SNAP-IV), Clinical Global Impression-Severity (CGI-S), Clinical Global Impression-Improvement, and the side effect rating scale were measured at every visit. Remission rates were presented based on SNAP-IV and CGI-S, respectively. Results : The treatment retention rate at 12 weeks and at 20 weeks was 76.2% and 66.8%, respectively. Divided according to 6-8, 9-11, 12-14 and 15-18 years of age, younger children tended to show a statistically higher treatment retention rate (p=.02). Based on SNAP-IV and CGI scores, children with better response to medication showed tendencies of statistically higher treatment retention rate. The most common adverse events included loss of appetite (7.1%) and insomnia (3.3%). There was no serious adverse event related to the treatment, such as death. Conclusion : The use of OROS methylphenidate for treatment of ADHD was safe and tolerable for children. In this study, lower age and better treatment response showed a statistically significant relationship with higher treatment adherence. Boys showed a trend of high treatment adherence. The treatment adherence at 20 weeks was satisfactory, however, the treatment adherence after 20 weeks showed a sharp decrease. Therefore, treatment persistence for six months after the beginning of ADHD treatment is important. In addition, the positive role of psycho-education for children and parents is necessary for increasing treatment adherence.

• 정신신체의학
• /
• 제19권2호
• /
• pp.101-108
• /
• 2011

연구목적: 주의력결핍 과잉행동장애(Attention Deficit Hyperactivity Disorder, ADHD)와 간질 사이에서 나타나는 공통적 특성을 연구할 목적으로 Korea-Child Behavior Checklist(K-CBCL)과 ADHD Diagnostic System (ADS), Electroencephalogram(EEG)를 평가하여 두 질환군의 공통적 특성(Common features)을 알아보고자 하였다. 방 법: 6세부터 16세까지의 소아,청소년들을 대상으로 ADHD군 30명 간질군 34명 그리고 대조군은 29명이었다. 평가도구는 K-CBCL과 자가보고 도구인 ADS를 사용하였으며 뇌파를 측정하였다. 모든 결과의 분석은 다중변량분석(MANOVA)과 교차분석(${\chi}^2$-test)을 이용하였다. 결 과: 간질군, ADHD군 간의 공통적 특성으로 뇌파에서 비정상 뇌파 소견(대조군 13.8%, 간질군 97.1%, ADHD군 40%)을 보인 것과 ADS에서 부주의, 반응시간 표준편차 항목에서 유의미한 차이가 있음이 확인되었다. 결 론: 간질군과 ADHD군에서 비정상 뇌파 소견, 부주의, 반응시간 표준편차라는 공통적 특성이 있음을 확인하였다.

• Journal of the Korean Academy of Child and Adolescent Psychiatry
• /
• 제28권2호
• /
• pp.58-69
• /
• 2017

Attention-deficit hyperactivity disorder (ADHD) is a highly prevalent, impairing, and comorbid disorder that persists into adulthood. ADHD should be diagnosed in the same manner as other common adult mental health disorders. The three most important components in the comprehensive evaluation of patients with ADHD are the clinical interview, medical examination, and completion and scoring of behavior rating scales. The diagnostic evaluation of ADHD should include questions about the symptoms, family history, prior evaluation and treatment of ADHD, as well as other problems including alcohol and drug use. Screening interviews or rating scales, as well as interviews, should be used. When it is feasible, clinicians may wish to supplement these components of the evaluation with the objective assessments of the ADHD symptoms, such as through psychological tests. These tests are not essential to reaching a diagnosis, however, or to treatment planning, but may yield further information about the presence and severity of cognitive impairments that could be associated with some cases of ADHD. As comorbidity is the rule rather than the exception, clinicians should carefully screen for comorbid disorders as part of a comprehensive assessment of ADHD. To receive a diagnosis of ADHD, the person must be experiencing significant distress or impairment in his or her daily functioning, and must not meet the criteria for other mental disorders which might better account for the observed symptoms, such as mental retardation, autism or other pervasive developmental disorders, mood disorders and anxiety disorders. This report aims to suggest practice guidelines for the assessment and diagnosis of children, adolescents and adults with ADHD in Korea.